It is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis. it has been approved for renal cell carcinoma and soft tissue sarcoma by numerous regulatory administrations worldwide.
Voir plus de détails